The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

Visualizing cells after editing specific genes can help scientists learn new details about the function of those genes. But ...

The first batch of Apple Intelligence features, introducing Apple-built generative models and other enhancements to existing Apple software, launched in October, with more features rolling out in ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...

LG has unveiled a slew of new AI enhancements to this year's TV models at CES 2025. With artificial intelligence (AI) taking the tech industry by storm these last few years, you can expect to see ...

And it's a lot. As Apple tries to find its footing, iOS 18 is bombarded with so many AI features that it's sometimes hard to remember which new feature is where. In the past couple of months ...

Launched way back in April 2004, Gmail has now been around for over 20 years — and it boasts lots of great features that many users, for whatever reason, still aren’t taking advantage of.

Google announced on Wednesday that all AI features in Gmail, Docs, Sheets, and Meet are now available to Workspace customers at no extra charge, though the plan will see a $2 per month increase ...

Concerns have now been raised with Apple by multiple news organisations over the AI summary feature, which is available on iPhones with Apple Intelligence. The feature "must be revoked", the ...